Literature DB >> 12963698

The graft-versus-lymphoma effect: fact, fiction, or opportunity?

Michael R Bishop.   

Abstract

Mesh:

Year:  2003        PMID: 12963698     DOI: 10.1200/JCO.2003.05.984

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies.

Authors:  Rachel B Salit; Daniel H Fowler; Wyndham H Wilson; Robert M Dean; Steven Z Pavletic; Kieron Dunleavy; Frances Hakim; Terry J Fry; Seth M Steinberg; Thomas E Hughes; Jeanne Odom; Kelly Bryant; Ronald E Gress; Michael R Bishop
Journal:  J Clin Oncol       Date:  2012-02-06       Impact factor: 44.544

2.  Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation.

Authors:  M R Bishop; R M Dean; S M Steinberg; J Odom; S Z Pavletic; C Chow; S Pittaluga; C Sportes; N M Hardy; J Gea-Banacloche; A Kolstad; R E Gress; D H Fowler
Journal:  Ann Oncol       Date:  2008-08-05       Impact factor: 32.976

3.  Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation.

Authors:  Seth M Pollack; Seth M Steinberg; Jeanne Odom; Robert M Dean; Daniel H Fowler; Michael R Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2009-02       Impact factor: 5.742

4.  Graft-versus-lymphoma effect in a 64-year-old caucasian woman after allogeneic stem-cell transplantation: a case report.

Authors:  Gerhard Behre; Thomas Weber; Sebastian Theurich; Maximilian Christopeit
Journal:  J Med Case Rep       Date:  2009-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.